Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Jackson

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
BMC Public Health|March 11, 2011
Training initiatives within the AFHSC-Global Emerging Infections Surveillance and Response System: support for IHR (2005)Jean L Otto, Priya Baliga, Jose L Sanchez, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
BMC Public Health|March 11, 2011
Training initiatives within the AFHSC-Global Emerging Infections Surveillance and Response System: support for IHR (2005)Jean L Otto, Priya Baliga, Jose L Sanchez, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Pageof 9